BACKGROUND AND OBJECTIVES: Cognitive impairment is common among persons with chronic kidney disease, but the extent to which nontraditional vascular risk factors mediate this association is unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted cross-sectional analyses of baseline data collected from adults with chronic kidney disease participating in the Chronic Renal Insufficiency Cohort study. Cognitive impairment was defined as a Modified Mini-Mental State Exam score>1 SD below the mean score. RESULTS: Among 3591 participants, the mean age was 58.2±11.0 years, and the mean estimated GFR (eGFR) was 43.4±13.5 ml/min per 1.73 m2. Cognitive impairment was present in 13%. After adjustment for demographic characteristics, prevalent vascular disease (stroke, coronary artery disease, and peripheral arterial disease) and traditional vascular risk factors (diabetes, hypertension, smoking, and elevated cholesterol), an eGFR<30 ml/min per 1.73 m2 was associated with a 47% increased odds of cognitive impairment (odds ratio 1.47, 95% confidence interval 1.05, 2.05) relative to those with an eGFR 45 to 59 ml/min per 1.73 m2. This association was attenuated and no longer significant after adjustment for hemoglobin concentration. While other nontraditional vascular risk factors including C-reactive protein, homocysteine, serum albumin, and albuminuria were correlated with cognitive impairment in unadjusted analyses, they were not significantly associated with cognitive impairment after adjustment for eGFR and other confounders. CONCLUSIONS: The prevalence of cognitive impairment was higher among those with lower eGFR, independent of traditional vascular risk factors. This association may be explained in part by anemia.
BACKGROUND AND OBJECTIVES:Cognitive impairment is common among persons with chronic kidney disease, but the extent to which nontraditional vascular risk factors mediate this association is unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted cross-sectional analyses of baseline data collected from adults with chronic kidney disease participating in the Chronic Renal Insufficiency Cohort study. Cognitive impairment was defined as a Modified Mini-Mental State Exam score>1 SD below the mean score. RESULTS: Among 3591 participants, the mean age was 58.2±11.0 years, and the mean estimated GFR (eGFR) was 43.4±13.5 ml/min per 1.73 m2. Cognitive impairment was present in 13%. After adjustment for demographic characteristics, prevalent vascular disease (stroke, coronary artery disease, and peripheral arterial disease) and traditional vascular risk factors (diabetes, hypertension, smoking, and elevated cholesterol), an eGFR<30 ml/min per 1.73 m2 was associated with a 47% increased odds of cognitive impairment (odds ratio 1.47, 95% confidence interval 1.05, 2.05) relative to those with an eGFR 45 to 59 ml/min per 1.73 m2. This association was attenuated and no longer significant after adjustment for hemoglobin concentration. While other nontraditional vascular risk factors including C-reactive protein, homocysteine, serum albumin, and albuminuria were correlated with cognitive impairment in unadjusted analyses, they were not significantly associated with cognitive impairment after adjustment for eGFR and other confounders. CONCLUSIONS: The prevalence of cognitive impairment was higher among those with lower eGFR, independent of traditional vascular risk factors. This association may be explained in part by anemia.
Authors: Yelena Slinin; Misti L Paudel; Areef Ishani; Brent C Taylor; Kristine Yaffe; Anne M Murray; Howard A Fink; Eric S Orwoll; Steven R Cummings; Elizabeth Barrett-Connor; Simerjot Jassal; Kristine E Ensrud Journal: J Am Geriatr Soc Date: 2008-09-15 Impact factor: 5.562
Authors: Gregory M T Hare; Albert K Y Tsui; Anya T McLaren; Tenille E Ragoonanan; Julie Yu; C David Mazer Journal: Anesth Analg Date: 2008-10 Impact factor: 5.108
Authors: Daniel E Weiner; Keith Bartolomei; Tammy Scott; Lori Lyn Price; John L Griffith; Irwin Rosenberg; Andrew S Levey; Marshal F Folstein; Mark J Sarnak Journal: Am J Kidney Dis Date: 2008-12-12 Impact factor: 8.860
Authors: Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto Journal: N Engl J Med Date: 2009-10-30 Impact factor: 91.245
Authors: Manjula Kurella Tamura; Virginia Wadley; Kristine Yaffe; Leslie A McClure; George Howard; Rodney Go; Richard M Allman; David G Warnock; William McClellan Journal: Am J Kidney Dis Date: 2008-06-30 Impact factor: 8.860
Authors: Joshua I Barzilay; Annette L Fitzpatrick; Jose Luchsinger; Sevil Yasar; Charles Bernick; Nancy S Jenny; Lewis H Kuller Journal: Am J Kidney Dis Date: 2008-05-12 Impact factor: 8.860
Authors: Lewis H Kuller; Oscar L Lopez; Anne Newman; Norman J Beauchamp; Greg Burke; Corinne Dulberg; Annette Fitzpatrick; Linda Fried; Mary N Haan Journal: Neuroepidemiology Date: 2003 Jan-Feb Impact factor: 3.282
Authors: M Arfan Ikram; Meike W Vernooij; Albert Hofman; Wiro J Niessen; Aad van der Lugt; Monique M B Breteler Journal: Stroke Date: 2007-11-29 Impact factor: 7.914
Authors: Tali Cukierman-Yaffe; Hertzel C Gerstein; Jeff D Williamson; Ronald M Lazar; Laura Lovato; Michael E Miller; Laura H Coker; Anne Murray; Mark D Sullivan; Santica M Marcovina; Lenore J Launer Journal: Diabetes Care Date: 2009-02 Impact factor: 17.152
Authors: Manjula Kurella Tamura; Paul Muntner; Virginia Wadley; Mary Cushman; Neil A Zakai; Brian D Bradbury; Brett Kissela; Fred Unverzagt; George Howard; David Warnock; William McClellan Journal: Am J Kidney Dis Date: 2011-08-04 Impact factor: 8.860
Authors: Arpita Basu; Alicia J Jenkins; Julie A Stoner; Suzanne R Thorpe; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; Timothy J Lyons Journal: Atherosclerosis Date: 2014-07-15 Impact factor: 5.162
Authors: David A Drew; Hocine Tighiouart; Jasmine Rollins; Sarah Duncan; Seda Babroudi; Tammy Scott; Daniel E Weiner; Mark J Sarnak Journal: J Am Soc Nephrol Date: 2020-03-04 Impact factor: 10.121
Authors: Anna C Porter; James P Lash; Dawei Xie; Qiang Pan; Jennifer DeLuca; Radhika Kanthety; John W Kusek; Claudia M Lora; Lisa Nessel; Ana C Ricardo; Julie Wright Nunes; Michael J Fischer Journal: Clin J Am Soc Nephrol Date: 2016-05-31 Impact factor: 8.237
Authors: Mara A McAdams-DeMarco; Jingwen Tan; Megan L Salter; Alden Gross; Lucy A Meoni; Bernard G Jaar; Wen-Hong Linda Kao; Rulan S Parekh; Dorry L Segev; Stephen M Sozio Journal: Clin J Am Soc Nephrol Date: 2015-11-16 Impact factor: 8.237